DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were gingivally injected in WT and MyD88-/- mice after ligature-induced necrosis (n = 6 per each group). (A) 3D rendering of confocal fluorescence image analysis revealed dramatic reduction of proinflammatory cytokines TNF-α (red) and IL-6 (green) by immunostaining (cerebral cortex area) and ELISA (B and C) in MyD88-/- after 24 h of injection (A section: Scale bar = 80 μm). (D) Aa-20050 in the brain was measured using qRT-PCR following intragingival injection of Aa EVs. For qRT-PCR, Cel-miR-39-3p was added (spike-in) for normalization. Data are presented as mean ± SD from six independent experiments. (E) Brain tissues were analyzed by western blotting in response to Aa ...
<p>Mice were infected with γHV-68 (black bars) or MEM only (open bars). Five weeks p.i. EAE was indu...
<p>Intraperitoneal injections of 5 mg/kg LPS were administered to 4–6 four-weeks-old Eif2b5<sup>R132...
<p>Mice received an intravenous injection of 40 µg <i>eGFP</i>-MiLV and <i>pEGFP-N3</i> plasmid. At ...
DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were gingivally injected in ...
DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were injected in WT and MyD8...
DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were intragingivally injecte...
(A) Schematic diagram of the in vivo experimental design. DiD-labeled Aa EVs (approximately 2.25 × 1...
(A) Schematic diagram of the in vivo experimental design. Gelatin gels (50 μl) including DiD-labeled...
Gelatin gels including DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were ...
(A) General scheme of the in vivo experimental design. Purified Aa EVs were quantified using NTS dev...
<p>Mice were infected i.p. with γHV-68 (black bars) or MEM only (open bars). Five weeks p.i., EAE wa...
<p>B6 (closed bars), <i>Gt</i> (open bars), <i>MyD88<sup>−/−</sup></i> (lined bars) and <i>MyD88<sup...
<p>(<b>A</b> and <b>B</b>) Relative expression of <i>Il1b</i>, <i>Tnfa</i>, and <i>Il10</i> mRNAs in...
<p><b>a.</b> Total RNA from the brain (cortex), peripheral blood (PB) and/or representative control ...
The concentrations of IL-6, TNF-α, IL-1β, MCP-1and IL-10 in the brains (A-E) and lungs (F-J) of mice...
<p>Mice were infected with γHV-68 (black bars) or MEM only (open bars). Five weeks p.i. EAE was indu...
<p>Intraperitoneal injections of 5 mg/kg LPS were administered to 4–6 four-weeks-old Eif2b5<sup>R132...
<p>Mice received an intravenous injection of 40 µg <i>eGFP</i>-MiLV and <i>pEGFP-N3</i> plasmid. At ...
DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were gingivally injected in ...
DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were injected in WT and MyD8...
DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were intragingivally injecte...
(A) Schematic diagram of the in vivo experimental design. DiD-labeled Aa EVs (approximately 2.25 × 1...
(A) Schematic diagram of the in vivo experimental design. Gelatin gels (50 μl) including DiD-labeled...
Gelatin gels including DiD-labeled Aa EVs (approximately 2.25 × 109 particles in 50 μl of PBS) were ...
(A) General scheme of the in vivo experimental design. Purified Aa EVs were quantified using NTS dev...
<p>Mice were infected i.p. with γHV-68 (black bars) or MEM only (open bars). Five weeks p.i., EAE wa...
<p>B6 (closed bars), <i>Gt</i> (open bars), <i>MyD88<sup>−/−</sup></i> (lined bars) and <i>MyD88<sup...
<p>(<b>A</b> and <b>B</b>) Relative expression of <i>Il1b</i>, <i>Tnfa</i>, and <i>Il10</i> mRNAs in...
<p><b>a.</b> Total RNA from the brain (cortex), peripheral blood (PB) and/or representative control ...
The concentrations of IL-6, TNF-α, IL-1β, MCP-1and IL-10 in the brains (A-E) and lungs (F-J) of mice...
<p>Mice were infected with γHV-68 (black bars) or MEM only (open bars). Five weeks p.i. EAE was indu...
<p>Intraperitoneal injections of 5 mg/kg LPS were administered to 4–6 four-weeks-old Eif2b5<sup>R132...
<p>Mice received an intravenous injection of 40 µg <i>eGFP</i>-MiLV and <i>pEGFP-N3</i> plasmid. At ...